[Federal Register Volume 85, Number 16 (Friday, January 24, 2020)]
[Notices]
[Page 4343]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01127]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
teleconference meeting of the Advisory Committee on the Medical Uses of
Isotopes (ACMUI) on March 11, 2020, to discuss the draft report of the
ACMUI Regulatory Guide 8.39 Subcommittee. A phased approach is being
conducted by the NRC staff to comprehensively update Regulatory Guide
8.39, ``Release of Patients Administered Radioactive Material.'' Phase
1 of the revision provides licensees with more detailed instructions to
patients before and after they have been administered radioactive
material than what is currently provided in Regulatory Guide 8.39. The
ACMUI subcommittee's report will include its comments and
recommendations on the draft final Phase 1 revisions to Regulatory
Guide 8.39. Meeting information, including a copy of the agenda and
handouts, will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html. The agenda and handouts may also
be obtained by contacting Ms. Kellee Jamerson using the information
below.
DATES: The teleconference meeting will be held on Wednesday, March 11,
2020, 2:00 p.m. to 4:00 p.m. Eastern Time.
FOR FURTHER INFORMATION CONTACT: Kellee Jamerson, email:
[email protected], telephone: (301) 415-7408.
SUPPLEMENTARY INFORMATION:
Public Participation: Any member of the public who wishes to
participate in the teleconference should contact Ms. Jamerson using the
contact information in FOR FURTHER INFORMATION CONTACT.
Conduct of the Meeting
Dr. Darlene Metter, ACMUI Chairman, will preside over the meeting.
Dr. Metter will conduct the meeting in a manner that will facilitate
the orderly conduct of business. The following procedures apply to
public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Jamerson at the contact information listed
above. All written statements must be received by March 6, 2020, three
business days prior to the meeting, and must pertain to the topic on
the agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html on or about April 22, 2020.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in 10
CFR part 7.
Dated: January 17, 2020.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2020-01127 Filed 1-23-20; 8:45 am]
BILLING CODE 7590-01-P